Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Holoclar, ex vivo expanded autologous human corneal epithelial cells containing stem cells, Date of authorisation: 17/02/2015, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 17, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Stronghold Plus, selamectin,sarolaner, Status: Authorised

Veterinary medicines European public assessment report (EPAR): NexGard Combo, esafoxolaner,eprinomectin,praziquantel, Status: Authorised

PSUSA/00001048/202409

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND+Gm+REOm+EDS, avian infectious bronchitis,Newcastle disease,avian infectious bursal disease,avian reovirus,egg drop syndrome virus vaccine (inactivated), Status: Authorised

Human medicines European public assessment report (EPAR): Latuda, lurasidone, Date of authorisation: 21/03/2014, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Circadin, melatonin, Date of authorisation: 29/06/2007, Revision: 37, Status: Authorised